Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia
- 1 April 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (4) , 764-765
- https://doi.org/10.1038/sj.leu.2402428
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphismBlood, 2001
- Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemiaBritish Journal of Haematology, 2000
- MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)Annals of Oncology, 2000
- Polymorphisms of Methylenetetrahydrofolate Reductase and Other Enzymes: Metabolic Significance, Risks and Impact on Folate RequirementJournal of Nutrition, 1999
- Differential Methotrexate Resistance in Childhood T- Versus Common/PreB-Acute Lymphoblastic Leukemia Can Be Measured by an In Situ Thymidylate Synthase Inhibition Assay, But Not by the MTT AssayBlood, 1999
- Molecular and Cellular Correlates of Methotrexate Response in Childhood Acute Lymphoblastic LeukemiaLeukemia & Lymphoma, 1999
- Increased Frequency of Expression of Elevated Dihydrofolate Reductase in T-Cell Versus B-Precursor Acute Lymphoblastic Leukemia in ChildrenBlood, 1997
- Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemiaBlood, 1995